Matches in Wikidata for { <http://www.wikidata.org/entity/Q58575585> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q58575585 description "article scientifique publié en 2018" @default.
- Q58575585 description "artículu científicu espublizáu en payares de 2018" @default.
- Q58575585 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58575585 description "scientific article published on 01 November 2018" @default.
- Q58575585 description "wetenschappelijk artikel" @default.
- Q58575585 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q58575585 name "Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial" @default.
- Q58575585 name "Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial" @default.
- Q58575585 type Item @default.
- Q58575585 label "Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial" @default.
- Q58575585 label "Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial" @default.
- Q58575585 prefLabel "Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial" @default.
- Q58575585 prefLabel "Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial" @default.
- Q58575585 P1433 Q58575585-C7E326F1-77F0-4549-85A3-7ACCB1ACBB72 @default.
- Q58575585 P1476 Q58575585-233D6ABA-20E9-4D92-821D-5489E168D3C4 @default.
- Q58575585 P2093 Q58575585-09C7C7A6-58E0-490C-85CC-216822ABC75D @default.
- Q58575585 P2093 Q58575585-3838CF7E-97D5-4277-830C-0B82FA242DC9 @default.
- Q58575585 P2093 Q58575585-627AA8AE-583F-4186-9185-D0A46B00F337 @default.
- Q58575585 P2093 Q58575585-680E949F-A18A-4AAA-8462-64AFFE2F22AF @default.
- Q58575585 P2093 Q58575585-85C3F274-E13F-438C-A6E0-36EAEB070741 @default.
- Q58575585 P2093 Q58575585-A4504C40-B2DF-428C-A166-F2F7C1DE44C1 @default.
- Q58575585 P2093 Q58575585-CA976EFF-F751-4786-862E-42D82C8388BE @default.
- Q58575585 P304 Q58575585-61F3214B-C28D-4D8E-B3D6-3CF04ED60979 @default.
- Q58575585 P31 Q58575585-8C9556AE-BA2F-49B1-A79F-D966F8C39ADF @default.
- Q58575585 P356 Q58575585-CDD26F93-A1A1-4706-A41A-9337E882FDAA @default.
- Q58575585 P407 Q58575585-D5B9AFE4-2620-4F10-B424-A34EC2B45F38 @default.
- Q58575585 P433 Q58575585-FC89F910-69F4-4878-9811-E37395949933 @default.
- Q58575585 P478 Q58575585-FC02822D-985B-4CD3-8AA1-9E2DC62776D8 @default.
- Q58575585 P50 Q58575585-0B161AC1-3620-4EB7-9C19-B5FA6D782DD8 @default.
- Q58575585 P50 Q58575585-5E1BFF30-C1DB-4CFA-938F-B2A21AA1C62E @default.
- Q58575585 P50 Q58575585-C38C4DB2-DEC0-43E5-849A-D7D6EDF65736 @default.
- Q58575585 P577 Q58575585-B966108B-084C-440C-8CB0-44E4077DFC71 @default.
- Q58575585 P698 Q58575585-5FABE8FF-79C5-49B6-8A62-AE2C4A4028E5 @default.
- Q58575585 P921 Q58575585-1319523F-4AB0-45E2-B890-088BAD840B9A @default.
- Q58575585 P921 Q58575585-1D205DB6-A013-4320-82A9-CFF12E1A07E9 @default.
- Q58575585 P921 Q58575585-797EBA0A-5A7B-42DF-9756-97F189B3D1AE @default.
- Q58575585 P356 FPC.0000000000000354 @default.
- Q58575585 P698 30334909 @default.
- Q58575585 P1433 Q10534561 @default.
- Q58575585 P1476 "Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial" @default.
- Q58575585 P2093 "Anna González-Neira" @default.
- Q58575585 P2093 "Daniela Caronia" @default.
- Q58575585 P2093 "Fernando Moreno" @default.
- Q58575585 P2093 "Guillermo Pita" @default.
- Q58575585 P2093 "Leticia T Moreno" @default.
- Q58575585 P2093 "Miguel Martin" @default.
- Q58575585 P2093 "Sara Ruiz-Pinto" @default.
- Q58575585 P304 "245-250" @default.
- Q58575585 P31 Q13442814 @default.
- Q58575585 P356 "10.1097/FPC.0000000000000354" @default.
- Q58575585 P407 Q1860 @default.
- Q58575585 P433 "11" @default.
- Q58575585 P478 "28" @default.
- Q58575585 P50 Q56856067 @default.
- Q58575585 P50 Q57049977 @default.
- Q58575585 P50 Q58453018 @default.
- Q58575585 P577 "2018-11-01T00:00:00Z" @default.
- Q58575585 P698 "30334909" @default.
- Q58575585 P921 Q18936 @default.
- Q58575585 P921 Q420436 @default.
- Q58575585 P921 Q42824440 @default.